Literature DB >> 6275413

The development of gamma-emitting hormone analogs as imaging agents for receptor-positive tumors.

J A Katzenellenbogen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6275413

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  3 in total

Review 1.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors:  D A Mankoff; F Dehdashti; A F Shields
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Diagnostic and Prognostic Role of 18F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept.

Authors:  Francesco Fiz; Gianluca Bottoni; Giorgio Treglia; Pierpaolo Trimboli; Arnoldo Piccardo
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

Review 3.  The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors:  John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2020-02-22       Impact factor: 2.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.